Baroda BNP Paribas Manufacturing Fund
(An open-ended equity scheme predominantly investing in Manufacturing theme)
Baroda BNP Paribas Manufacturing Fund
(An open-ended equity scheme predominantly investing in Manufacturing theme)
March 2025

March 2025


Investment Objective

The investment objective is to generate long-term capital appreciation from a portfolio invested predominantly in equity and equity related securities of companies engaged in Manufacturing
The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.

NAV Details (As on March 28, 2025)
Regular Plan - IDCW Option : ₹8.7441
Regular Plan - Growth Option : ₹8.7441
Direct Plan - IDCW Option : ₹8.8505
Direct Plan - Growth Option : ₹8.8505
 
Benchmark Index (Tier 1)

Nifty India Manufacturing TRI

Date of Allotment

June 28, 2024

Fund Manager
Fund Manager Managing fund since Experience
Jitendra Sriram 28-Jun-24 27 years
Mr. Kushant Arora 21-Oct-24 11 years
Load Structure

Exit Load: • If units of the Scheme are redeemed or switched out up to 10% of the units within 1 year from the date of allotment - Nil. • If units of the Scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of Scheme are redeemed or switched out after 1 year from the date of allotment - Nil.

For detailed load structure please refer Scheme Information Document.

Lumpsum Details

Minimum Amount: Lumpsum investment:
₹ 1,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on March 28, 2025 : ₹ 1,205.16 Crores
AUM## As on March 28, 2025 : ₹ 1,228.99 Crores

## including inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Pharmaceuticals & Biotechnology 21.99%
Divi's Laboratories Limited 7.82%
Sun Pharmaceutical IndustriesLimited 5.59%
Dr. Reddy's Laboratories Limited 2.51%
AstraZeneca Pharma India Limited 2.40%
Cipla Limited 2.02%
IPCA Laboratories Limited 1.65%
Automobiles 12.47%
Mahindra & Mahindra Limited 3.51%
Maruti Suzuki India Limited 2.53%
Tata Motors Limited 2.12%
Hero MotoCorp Limited 2.04%
Hyundai Motor India Ltd 1.38%
TVS Motor Company Limited 0.89%
Petroleum Products 10.33%
Reliance Industries Limited 7.28%
Bharat Petroleum Corporation Limited 2.04%
Gulf Oil Lubricants India Limited 1.01%
Auto Components 7.54%
Bosch Limited 3.95%
ZF Commercial Vehicle ControlSystems India Limited 1.62%
Amara Raja Energy & Mobility Ltd 1.03%
Jtekt India Limited 0.94%
Industrial Products 5.43%
Cummins India Limited 1.23%
SKF India Limited 1.11%
KSB Limited 1.08%
Ingersoll Rand (India) Limited 1.03%
Grindwell Norton Limited 0.98%
Electrical Equipment 5.43%
Hitachi Energy India Limited 2.87%
Bharat Heavy Electricals Limited 1.74%
GE Vernova T&D India Limited 0.82%
Chemicals & Petrochemicals 4.11%
Linde India Limited 1.83%
BASF India Limited 1.30%
Vinati Organics Limited 0.98%
Diversified Metals 3.87%
Vedanta Limited 3.87%
Industrial Manufacturing 3.39%
Tega Industries Limited 1.50%
Honeywell Automation India Limited 0.99%
Kennametal India Limited 0.90%
Agricultural, Commercial &Construction Vehicles 2.14%
Escorts Kubota Limited 2.14%
Aerospace & Defense 2.10%
Bharat Electronics Limited 2.10%
Fertilizers & Agrochemicals 2.05%
Sumitomo Chemical India Limited 2.05%
Cement & Cement Products 1.69%
UltraTech Cement Limited 1.69%
Non - Ferrous Metals 1.67%
National Aluminium Company Limited 1.67%
Beverages 1.44%
United Spirits Limited 1.44%
Diversified 1.38%
3M India Limited 1.38%
Gas 1.32%
Mahanagar Gas Limited 1.32%
Power 0.90%
NLC India Limited 0.90%
LESS THAN 0.75% EXPOSURE 3.55%
TOTAL EQUITY HOLDING 92.8%
FIXED INCOME HOLDINGS Rating % of Net Assets
Treasury Bill 1.97%
364 Days Tbill (MD 07/08/2025) SOV 1.19%
364 Days Tbill (MD 18/12/2025) SOV 0.78%
Total Fixed Income Holdings 1.97%
TREPS, Cash & Other Net Current Assets 5.23%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 42.33% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here

The scheme currently does not have Distribution History

TER - Regular Plan (%) 2.10%
TER - Direct Plan (%) 0.59%
Portfolio Turnover Ratio 0.50

* The information contained in this report has been obtained from sources considered to be authentic and reliable. This quantitative data does not purport to be an offer for purchase and sale of mutual fund units.

No of Stocks 50
Portfolio RoE (%) 16.30
EPS Growth (%) 35.59

This product is suitable for investors who are seeking*:

➤ Long term capital appreciation.
➤ Investing in equity and equity related securities of companies engaged in manufacturing theme.

*Investors should consult their nancial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty India Manufacturing TRI): basis it’s constituents; As on March 28, 2025

For complete portfolio, kindly refer the website https://www.barodabnpparibasmf.in/
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.